- Home
- ROIV vs WAL Comparison
ROIV vs WAL Comparison
Compare ROIV & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- WAL
- Stock Information
- Founded
- ROIV 2014
- WAL 1994
- Country
- ROIV United Kingdom
- WAL United States
- Employees
- ROIV N/A
- WAL N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- WAL Major Banks
- Sector
- ROIV Health Care
- WAL Finance
- Exchange
- ROIV Nasdaq
- WAL Nasdaq
- Market Cap
- ROIV 8.4B
- WAL 7.8B
- IPO Year
- ROIV N/A
- WAL 2005
- Fundamental
- Price
- ROIV $10.79
- WAL $78.18
- Analyst Decision
- ROIV Buy
- WAL Strong Buy
- Analyst Count
- ROIV 4
- WAL 15
- Target Price
- ROIV $17.50
- WAL $95.13
- AVG Volume (30 Days)
- ROIV 5.9M
- WAL 1.0M
- Earning Date
- ROIV 05-29-2025
- WAL 04-21-2025
- Dividend Yield
- ROIV N/A
- WAL 1.93%
- EPS Growth
- ROIV N/A
- WAL 6.13
- EPS
- ROIV N/A
- WAL 7.28
- Revenue
- ROIV $122,585,000.00
- WAL $3,049,400,000.00
- Revenue This Year
- ROIV N/A
- WAL $13.26
- Revenue Next Year
- ROIV N/A
- WAL $9.87
- P/E Ratio
- ROIV N/A
- WAL $10.85
- Revenue Growth
- ROIV 140.04
- WAL 11.37
- 52 Week Low
- ROIV $8.73
- WAL $56.70
- 52 Week High
- ROIV $13.06
- WAL $98.10
- Technical
- Relative Strength Index (RSI)
- ROIV 50.06
- WAL 61.58
- Support Level
- ROIV $10.58
- WAL $70.45
- Resistance Level
- ROIV $11.77
- WAL $80.47
- Average True Range (ATR)
- ROIV 0.34
- WAL 2.11
- MACD
- ROIV -0.07
- WAL 1.07
- Stochastic Oscillator
- ROIV 17.65
- WAL 78.52
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.